Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.

Dragonetti, Daniela; Guarini, Giuseppe; Pizzuti, Michele

Dragonetti, Daniela; Guarini, Giuseppe; Pizzuti, Michele.

Dragonetti D; Department of Clinical Laboratory, "San Carlo" Regional Hospital, Potenza, Italy.
Guarini G; COVID Intensive Care, "San Carlo" Regional Hospital, Potenza, Italy.
Pizzuti M; Department of Hematology, "San Carlo" Regional Hospital, Potenza, Italy.

Blood Transfus ; 18(4): 328, 2020 07.

Article in English | MEDLINE | ID: covidwho-663443

Subject(s)

Anticoagulants/immunology; Autoantibodies/blood; Betacoronavirus; Coronavirus Infections/immunology; Heparin, Low-Molecular-Weight/immunology; Heparin/immunology; Platelet Factor 4/immunology; Pneumonia, Viral/immunology; Purpura, Thrombocytopenic, Idiopathic/chemically induced; Thrombophilia/drug therapy; Antibody Specificity; Anticoagulants/therapeutic use; Autoantibodies/immunology; COVID-19; Coronavirus Infections/blood; Coronavirus Infections/complications; Fondaparinux/pharmacology; Fondaparinux/therapeutic use; Heparin/therapeutic use; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Pandemics; Platelet Count; Pneumonia, Viral/blood; Pneumonia, Viral/complications; Purpura, Thrombocytopenic, Idiopathic/immunology; SARS-CoV-2; Thrombophilia/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Autoantibodies / Platelet Factor 4 / Heparin / Purpura, Thrombocytopenic, Idiopathic / Coronavirus Infections / Heparin, Low-Molecular-Weight / Thrombophilia / Betacoronavirus / Anticoagulants Type of study: Diagnostic study Topics: Long Covid Limits: Humans Language: English Journal: Blood Transfus Year: 2020 Document Type: Article Affiliation country: 2020.0164-20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google